Floatz logo

17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE

Opioid Induced Constipation

S.L.A. Pharma AGSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Opioid Induced Constipation cohort.

Asset / SponsorPhaseRating
Prucalopride
Shire
Phase 3B
MORPHINAN-3,6,14-TRIOL, 4,5-EPOXY-17-(2-PROPENYL)-, (5.ALPHA.,6.BETA.)-
S.L.A. Pharma AG
Phase 2B

Same molecule, other indications

17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE is also rated in:

Low Back PainDormant
BBB
Indicative ·
74 / 100
View asset →
PainDormant
BBB
Indicative ·
73 / 100
View asset →
Chronic OsteoarthritisDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →